Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polyzois Makras

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Bone|September 21, 2021
Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosisPiet Geusens, Robert Feldman, Mary Oates, et al.
Forensic Science International. Genetics|September 6, 2024
Comparison of next generation sequencing (NGS) - (SNPs) and capillary electrophoresis (CE) - (STRs) in the genetic analysis of human remainsStavros Kokotas, Bruce Budowle, Athanasios Papatheodorou, et al.
Reviews in Endocrine & Metabolic Disorders|August 20, 2024
Primary hyperparathyroidism: from guidelines to outpatient clinicAndrea Palermo, Gaia Tabacco, Polyzois Makras, et al.
Calcified Tissue International|January 2, 2021
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2018
Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Maria Pikilidou, et al.
Clinical Endocrinology|June 9, 2012
The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Sideris Delaroudis, et al.
Archives of Osteoporosis|January 4, 2020
Experience gained from the implementation of the fracture liaison service in GreecePolyzois Makras, George C Babis, Efstathios Chronopoulos, et al.
Endocrine|May 23, 2023
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control studyAthanasios D Anastasilakis, Stergios A Polyzos, Matthaios Savvidis, et al.
Hormones (Athens, Greece)|November 24, 2018
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatmentStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Biomedicines|December 16, 2020
Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone DisorderMaria P Yavropoulou, Vasilios Vaios, Polyzois Makras, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Bone|September 21, 2021
Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosisPiet Geusens, Robert Feldman, Mary Oates, et al.
Forensic Science International. Genetics|September 6, 2024
Comparison of next generation sequencing (NGS) - (SNPs) and capillary electrophoresis (CE) - (STRs) in the genetic analysis of human remainsStavros Kokotas, Bruce Budowle, Athanasios Papatheodorou, et al.
Reviews in Endocrine & Metabolic Disorders|August 20, 2024
Primary hyperparathyroidism: from guidelines to outpatient clinicAndrea Palermo, Gaia Tabacco, Polyzois Makras, et al.
Calcified Tissue International|January 2, 2021
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2018
Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Maria Pikilidou, et al.
Clinical Endocrinology|June 9, 2012
The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Sideris Delaroudis, et al.
Archives of Osteoporosis|January 4, 2020
Experience gained from the implementation of the fracture liaison service in GreecePolyzois Makras, George C Babis, Efstathios Chronopoulos, et al.
Endocrine|May 23, 2023
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control studyAthanasios D Anastasilakis, Stergios A Polyzos, Matthaios Savvidis, et al.
Hormones (Athens, Greece)|November 24, 2018
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatmentStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Biomedicines|December 16, 2020
Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone DisorderMaria P Yavropoulou, Vasilios Vaios, Polyzois Makras, et al.
Pageof 13